Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vascular Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 607 articles:
HTML format



Single Articles


    November 2021
  1. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    PubMed    


  2. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    PubMed     Abstract available


    October 2021
  3. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    PubMed     Abstract available


  4. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    PubMed    


  5. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed     Abstract available


  6. ZGHOUZI M, Moussa Pacha H, Ullah W, Sattar Y, et al
    In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease.
    Catheter Cardiovasc Interv. 2021;98:E586-E593.
    PubMed     Abstract available


  7. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed     Abstract available


  8. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  9. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed     Abstract available


  10. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  11. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed     Abstract available


  12. YELAVARTHY P, Seth M, Pielsticker E, Grines CL, et al
    The DISCO study-Does Interventionalists' Sex impact Coronary Outcomes?
    Catheter Cardiovasc Interv. 2021;98:E531-E539.
    PubMed     Abstract available


  13. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed     Abstract available


  14. RAMASAMY A, Bajaj R, Jones DA, Amersey R, et al
    Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years.
    Catheter Cardiovasc Interv. 2021;98:649-655.
    PubMed     Abstract available


  15. MIDULLA M, Chevallier O, Comby PO, Giordano G, et al
    Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020.
    Catheter Cardiovasc Interv. 2021;98:748-755.
    PubMed     Abstract available


  16. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed     Abstract available


  17. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed     Abstract available


  18. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


  19. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed     Abstract available


    September 2021
  20. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    PubMed    


  21. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  22. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed    


  23. STABILE E, Esposito G
    Below the knee percutaneous transluminal angioplasty for claudicants: One vessel is enough to relieve symptoms.
    Catheter Cardiovasc Interv. 2021;98:570-571.
    PubMed     Abstract available


  24. POSTALIAN A, Krajcer Z
    MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
    Catheter Cardiovasc Interv. 2021;98:586-587.
    PubMed     Abstract available


  25. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed     Abstract available


  26. ROCHA-SINGH KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, et al
    Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Catheter Cardiovasc Interv. 2021;98:549-558.
    PubMed     Abstract available


  27. SALAHUDDIN T, Giannopoulos S, Adams G, Armstrong EJ, et al
    Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
    Catheter Cardiovasc Interv. 2021;98:559-569.
    PubMed     Abstract available


  28. KATSUKI T, Yamaji K, Soga Y, Iida O, et al
    New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
    Catheter Cardiovasc Interv. 2021;98:E395-E402.
    PubMed     Abstract available


  29. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  30. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms.
    Catheter Cardiovasc Interv. 2021;98:E462-E465.
    PubMed     Abstract available


  31. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  32. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed     Abstract available


  33. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed     Abstract available


  34. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed     Abstract available


  35. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed     Abstract available


  36. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  37. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  38. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


  39. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed     Abstract available


  40. SHAH R, Labroo A, Davis DA, Le FK, et al
    Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after PCI: A meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:E490-E492.
    PubMed    


  41. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed     Abstract available


    August 2021
  42. JIA X, Jneid H
    Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned.
    Catheter Cardiovasc Interv. 2021;98:223-224.
    PubMed    


  43. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    PubMed     Abstract available


  44. CAO D, Dangas GD
    Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
    Catheter Cardiovasc Interv. 2021;98:206-207.
    PubMed    


  45. WINSCOTT JG, Hillegass WB
    Critical limb ischemia in the end stage renal disease patient: Some next steps.
    Catheter Cardiovasc Interv. 2021;98:308-309.
    PubMed    


  46. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    PubMed    


  47. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  48. DAWSON DB, Telles-Garcia NA, Atkins JL, Mina GS, et al
    End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:297-307.
    PubMed     Abstract available


  49. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed     Abstract available


  50. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  51. PATHAN AZ, Aijaz S, Sheikh S, Sattar S, et al
    Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
    Catheter Cardiovasc Interv. 2021;98:E181-E187.
    PubMed     Abstract available


  52. KABIR R, Vuppala S, Liu Y, Tejani I, et al
    Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
    Catheter Cardiovasc Interv. 2021;98:310-316.
    PubMed     Abstract available


  53. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    PubMed    


  54. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    PubMed    


  55. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


  56. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed     Abstract available


  57. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed     Abstract available


  58. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed    


  59. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed     Abstract available


    July 2021
  60. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed    


  61. ICHIHASHI S, Tamura Y, Maeda S, Kichikawa K, et al
    Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation.
    Catheter Cardiovasc Interv. 2021;98:E124-E126.
    PubMed     Abstract available


  62. SULIMOV DS, Markuske M, Desch S, Thiele H, et al
    Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2021;98:E122-E123.
    PubMed     Abstract available


  63. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed     Abstract available


  64. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  65. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed     Abstract available


  66. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  67. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed     Abstract available


  68. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  69. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  70. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed     Abstract available


  71. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  72. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  73. RAHMAN F, Jneid H
    The continuing promise of the radial access for coronary interventions.
    Catheter Cardiovasc Interv. 2021;97:1397-1398.
    PubMed    


  74. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    PubMed    


  75. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  76. BEN-DOR I, Sharma A, Rogers T, Yerasi C, et al
    Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle.
    Catheter Cardiovasc Interv. 2021;97:1379-1385.
    PubMed     Abstract available


  77. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    PubMed    


  78. OKSNES A, McEntegart M
    Intravascular lithotripsy in saphenous vein grafts and graft stent failure: A case series.
    Catheter Cardiovasc Interv. 2021;97:E945-E950.
    PubMed     Abstract available


  79. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed     Abstract available


  80. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed     Abstract available


  81. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  82. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed     Abstract available


  83. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed     Abstract available


    May 2021
  84. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  85. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    PubMed     Abstract available


  86. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  87. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    PubMed    


  88. SHAH J, Levy MS
    GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients.
    Catheter Cardiovasc Interv. 2021;97:1160-1161.
    PubMed    


  89. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed     Abstract available


  90. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  91. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


  92. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed     Abstract available


  93. FUKAGAWA T, Mori S, Hirano K
    Feasibility of the novel proximal superficial femoral artery puncture technique to recanalize chronic total occlusions.
    Catheter Cardiovasc Interv. 2021;97:E852-E856.
    PubMed     Abstract available


  94. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed     Abstract available


  95. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  96. TESTI G, Ceccacci T, Maioli F, Grotti S, et al
    Medial-to-lateral plantar loop technique for retrograde transcollateral recanalization of the lateral plantar artery in patients with type 3 plantar arch.
    Catheter Cardiovasc Interv. 2021;97:E842-E846.
    PubMed     Abstract available


  97. ARANZULLA TC, Musumeci G
    Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;97:E835-E841.
    PubMed     Abstract available


  98. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed     Abstract available


  99. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed     Abstract available


  100. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed     Abstract available


  101. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed     Abstract available


  102. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed     Abstract available


  103. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed     Abstract available


  104. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed     Abstract available


  105. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed     Abstract available


  106. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  107. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


  108. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed     Abstract available


  109. ZHANG J, Qiu M, Na K, Ma S, et al
    Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1025-1031.
    PubMed     Abstract available


    April 2021
  110. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  111. ABIZAID A, Campos CM, Guimaraes PO, Costa JR Jr, et al
    Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
    Catheter Cardiovasc Interv. 2021 Apr 27. doi: 10.1002/ccd.29709.
    PubMed     Abstract available


  112. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    PubMed     Abstract available


  113. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    PubMed     Abstract available


  114. SHARMA SK, Fuster V, Hofstra L, Kini AS, et al
    Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19.
    Catheter Cardiovasc Interv. 2021;97:850-852.
    PubMed    


  115. LOPEZ JJ, Ebinger JE, Allen S, Yildiz M, et al
    Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.
    Catheter Cardiovasc Interv. 2021;97:847-849.
    PubMed     Abstract available


  116. QUESADA O, Henry TD
    New generation drug eluting stents: Closing the gap in sex disparity in cardiovascular outcomes in women.
    Catheter Cardiovasc Interv. 2021;97:805-806.
    PubMed    


  117. FARHAD H, Levy MS
    PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?
    Catheter Cardiovasc Interv. 2021;97:786-787.
    PubMed    


  118. NICOLAS J, Mehran R
    Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?
    Catheter Cardiovasc Interv. 2021;97:774-775.
    PubMed    


  119. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    PubMed    


  120. FUKAGAWA T, Hirano K, Mori S, Yamawaki M, et al
    Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2021;97:E697-E703.
    PubMed     Abstract available


  121. VERMA I, Chang EY, Kumar G, Sachdeva R, et al
    Catheter directed embolectomy of right atrial clot in transit-A case series.
    Catheter Cardiovasc Interv. 2021;97:869-873.
    PubMed     Abstract available


  122. CHOI CH, Hall JK, Malaver D, Applegate RJ, et al
    A novel technique for postclosure of large-bore sheaths using two Perclose devices.
    Catheter Cardiovasc Interv. 2021;97:905-909.
    PubMed     Abstract available


  123. MENDELSOHN FO, Holmes DR Jr, Hopkins LN
    Expanding the stroke team to include interventional cardiology.
    Catheter Cardiovasc Interv. 2021;97:874-875.
    PubMed     Abstract available


  124. OSMAN M, Syed M, Abdul Ghaffar Y, Patel B, et al
    Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.
    Catheter Cardiovasc Interv. 2021;97:E627-E635.
    PubMed     Abstract available


  125. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    PubMed     Abstract available


  126. PROTTY MB, Hussain HI, Gallagher S, Al-Raisi S, et al
    Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E653-E660.
    PubMed     Abstract available


  127. LEE CH, Ahn JM, Kang DY, Han M, et al
    Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:776-785.
    PubMed     Abstract available


  128. SHAIK A, Mosleh W, Dahal K, Pickett C, et al
    The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis.
    Catheter Cardiovasc Interv. 2021;97:836-840.
    PubMed     Abstract available


  129. KITANI S, Igarashi Y, Tsuchikane E, Nakamura S, et al
    Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Catheter Cardiovasc Interv. 2021;97:E614-E623.
    PubMed     Abstract available


  130. FABBIOCCHI F, Calligaris G, Bartorelli AL
    Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents.
    Catheter Cardiovasc Interv. 2021;97:E676-E679.
    PubMed     Abstract available


  131. NAZIR S, Ahuja KR, Virk HUH, Elzanaty A, et al
    A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:788-794.
    PubMed     Abstract available


  132. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


    March 2021
  133. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed     Abstract available


  134. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed     Abstract available


  135. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    PubMed     Abstract available


  136. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    PubMed     Abstract available


  137. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    PubMed     Abstract available


  138. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    PubMed     Abstract available


  139. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    PubMed     Abstract available


  140. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  141. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


  142. LIU S, Song C, Yin D, Wang Y, et al
    Impact of public health emergency response to COVID-19 on management and outcome for NSTEMI patients in Beijing: A single-center historic control.
    Catheter Cardiovasc Interv. 2021;97:E475-E483.
    PubMed     Abstract available


  143. SMALLING RW
    Pre-transfer/PCI with ticagrelor and heparin administration in STEMI patients may be beneficial but should we do more?
    Catheter Cardiovasc Interv. 2021;97:600-601.
    PubMed    


  144. AGARWAL SK, Uretsky BF
    Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion?
    Catheter Cardiovasc Interv. 2021;97:656-657.
    PubMed    


  145. ASHLEY KE, Hillegass WB
    Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
    Catheter Cardiovasc Interv. 2021;97:579-580.
    PubMed    


  146. PATEL NJ, Heuser RR
    "PROGRESS is our most important product": Adventures in CTO intervention.
    Catheter Cardiovasc Interv. 2021;97:668-669.
    PubMed    


  147. CASE BC, Satler LF
    The challenges of coronary no-reflow phenomenon.
    Catheter Cardiovasc Interv. 2021;97:612-613.
    PubMed    


  148. AREGULLIN EO, Mohammad Nijres B, Al-Khatib Y, Vettukattil J, et al
    Transcatheter Fontan completion using novel balloon and stent system.
    Catheter Cardiovasc Interv. 2021;97:679-684.
    PubMed     Abstract available


  149. N'DANDU Z, Bonilla J, Yousef GM, White CJ, et al
    Percutaneous deep vein arterialization: An emerging technique for no-option chronic limb-threatening ischemia patients.
    Catheter Cardiovasc Interv. 2021;97:685-690.
    PubMed     Abstract available


  150. MIHATOV N, Secemsky EA, Kereiakes DJ, Steg G, et al
    Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;97:569-578.
    PubMed     Abstract available


  151. AL NASEF M, Oslizlok P, Walsh KP
    Percutaneous transcatheter occlusion of left atrioventricular valve in a patient with single ventricle and severe atrioventricular valve regurgitation.
    Catheter Cardiovasc Interv. 2021;97:E510-E513.
    PubMed     Abstract available


  152. ENOMOTO Y, Egashira Y, Iwama T
    What's happening in carotid stent? A case report of prominent plaque protrusion after carotid artery stenting observed on angioscopy.
    Catheter Cardiovasc Interv. 2021;97:E532-E535.
    PubMed     Abstract available


  153. JOSHI FR, Lonborg J, Sadjadieh G, Helqvist S, et al
    The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
    Catheter Cardiovasc Interv. 2021;97:E467-E474.
    PubMed     Abstract available


  154. NAVARESE EP, Frediani L, Kandzari DE, Caiazzo G, et al
    Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
    Catheter Cardiovasc Interv. 2021;97:602-611.
    PubMed     Abstract available


  155. LEE SH, Choi KH, Lee JM, Shin D, et al
    Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.
    Catheter Cardiovasc Interv. 2021;97:E454-E466.
    PubMed     Abstract available


  156. WHITBECK MG, Chambers JW
    Single-access during Impella hemodynamic support utilizing the Railway system.
    Catheter Cardiovasc Interv. 2021;97:675-678.
    PubMed     Abstract available


  157. KAYAERT P, Coeman M, Drieghe B, Bennett J, et al
    iFR uncovers profound but mostly reversible ischemia in CTOs and helps to optimize PCI results.
    Catheter Cardiovasc Interv. 2021;97:646-655.
    PubMed     Abstract available


  158. NAKAJIMA A, Araki M, Kurihara O, Minami Y, et al
    Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:634-645.
    PubMed     Abstract available


    February 2021
  159. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed     Abstract available


  160. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed     Abstract available


  161. ROTHSTEIN ES, Welch TD, Andrus BW, Jayne JE, et al
    Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.
    Catheter Cardiovasc Interv. 2021;97:E333-E338.
    PubMed     Abstract available


  162. REILLY JP, Parikh PB
    PCI in TAVR patients: Timing isn't everything.
    Catheter Cardiovasc Interv. 2021;97:540-541.
    PubMed    


  163. RAZZOUK L, Jneid H
    Revascularization in patients with diabetes and chronic total occlusion: The journey or the destination?
    Catheter Cardiovasc Interv. 2021;97:384-385.
    PubMed    


  164. ALQAHTANI F, Osman M, Harris AH, Hohmann SF, et al
    Mortality and functional outcomes of endovascular stroke therapy in the United States.
    Catheter Cardiovasc Interv. 2021;97:470-474.
    PubMed     Abstract available


  165. ZHANG Y, Xiang D, Lu Q, Wu M, et al
    A systematic review and meta-analysis of the performance of flow-diverting stents in the treatment of peripheral and visceral artery aneurysms.
    Catheter Cardiovasc Interv. 2021;97:461-469.
    PubMed     Abstract available


  166. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  167. CHIABRANDO JG, Lombardi M, Vescovo GM, Wohlford GF, et al
    Stenting techniques for coronary bifurcation lesions: Evidence from a network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2021;97:E306-E318.
    PubMed     Abstract available


  168. MADDER RD, VanOosterhout S, Parker J, Sconzert K, et al
    Robotic telestenting performance in transcontinental and regional pre-clinical models.
    Catheter Cardiovasc Interv. 2021;97:E327-E332.
    PubMed     Abstract available


  169. YASUMURA K, Benhuri B, Vengrenyuk Y, Petrov A, et al
    Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
    Catheter Cardiovasc Interv. 2021;97:E280-E287.
    PubMed     Abstract available


  170. OSHEROV AB, Qiang B, Butany J, Wright GA, et al
    A calcified chronic total occlusion preclinical model.
    Catheter Cardiovasc Interv. 2021;97:437-442.
    PubMed     Abstract available


  171. ABHYANKAR A, Abizaid A, Chamie D, Rathod M, et al
    Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
    Catheter Cardiovasc Interv. 2021;97:423-430.
    PubMed     Abstract available


  172. FLORES-UMANZOR EJ, Cepas-Guillen PL, Vazquez S, Fernandez-Valledor A, et al
    Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
    Catheter Cardiovasc Interv. 2021;97:376-383.
    PubMed     Abstract available


  173. SAITO Y, Cristea E, Bouras G, Abizaid A, et al
    Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
    Catheter Cardiovasc Interv. 2021;97:431-436.
    PubMed     Abstract available


  174. YA'QOUB L, Gad M, Saad AM, Elgendy IY, et al
    National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29524.
    PubMed     Abstract available


  175. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    PubMed     Abstract available


  176. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  177. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  178. CHANGAL K
    Angiography versus fractional flow rate-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29540.
    PubMed    


  179. PICCOLO R, Esposito G
    Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?
    Catheter Cardiovasc Interv. 2021;97:199-200.
    PubMed    


  180. TARANTINI G, Nai Fovino L
    Negative impact of coronavirus on interventional cardiology fellows' training: Let's limit collateral damage of the pandemic.
    Catheter Cardiovasc Interv. 2021;97:206-207.
    PubMed    


  181. GUPTA T, Nazif TM, Vahl TP, Ahmad H, et al
    Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter.
    Catheter Cardiovasc Interv. 2021;97:201-205.
    PubMed     Abstract available


  182. SECCO GG, Tarantini G, Mazzarotto P, Garbo R, et al
    Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.
    Catheter Cardiovasc Interv. 2021;97:195-198.
    PubMed     Abstract available


  183. KAYANI WT, Jneid H
    Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern.
    Catheter Cardiovasc Interv. 2021;97:226-227.
    PubMed     Abstract available


  184. AGARWAL SK, Uretsky BF
    Toward a more perfect coronary intervention....
    Catheter Cardiovasc Interv. 2021;97:245-246.
    PubMed    


  185. KERN MJ, Seto AH
    How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al.
    Catheter Cardiovasc Interv. 2021;97:257-258.
    PubMed     Abstract available


  186. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    PubMed    


  187. CELIK O, Guner A, Kalcik M, Guler A, et al
    The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial).
    Catheter Cardiovasc Interv. 2021;97:301-309.
    PubMed     Abstract available


  188. BARRETT C, Warsavage T, Kovach C, McGuinn E, et al
    Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
    Catheter Cardiovasc Interv. 2021;97:E219-E226.
    PubMed     Abstract available


  189. GALLONE G, D'Ascenzo F, Conrotto F, Costa F, et al
    Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
    Catheter Cardiovasc Interv. 2021;97:E227-E236.
    PubMed     Abstract available


  190. TAMARU H, Fujii K, Otsuji S, Takiuchi S, et al
    Short- and mid-term influence of drug-coated stent implantation on structural and functional vascular healing response: An optical coherence tomography and acetylcholine testing study.
    Catheter Cardiovasc Interv. 2021;97:E186-E193.
    PubMed     Abstract available


  191. WATANABE Y, Mitomo S, Naganuma T, Kawamoto H, et al
    Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2021;97:E198-E208.
    PubMed     Abstract available


  192. HUSSAIN HI, Protty MB, Gallagher S, Al-Raisi S, et al
    The impact of coronary perforation in percutaneous interventions involving the left main stem coronary artery in the United Kingdom 2007-2014: Insights from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E179-E185.
    PubMed     Abstract available


  193. SHARMA RK, Poulin MF, Tamez-Aguilar H, Pinto DS, et al
    Post hoc closure of large bore vascular access using the MANTA closure device.
    Catheter Cardiovasc Interv. 2021;97:282-286.
    PubMed     Abstract available


    January 2021
  194. CHIARITO M, Cao D, Nicolas J, Roumeliotis A, et al
    Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.
    PubMed     Abstract available


  195. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    PubMed     Abstract available


  196. TARANTINI G, Fraccaro C
    Twilight-specific light cues.
    Catheter Cardiovasc Interv. 2021;97:72-73.
    PubMed     Abstract available


  197. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    PubMed     Abstract available


  198. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    PubMed     Abstract available


  199. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    PubMed     Abstract available


  200. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    PubMed     Abstract available


  201. CHUGH Y, Brilakis ES
    Intravascular lithotripsy for stent under-expansion: Panacea or Pandora's box?
    Catheter Cardiovasc Interv. 2021;97:30-31.
    PubMed     Abstract available


  202. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    PubMed     Abstract available


  203. MAESTAS CM, Blankenship JC
    Interventional economics provide a roadmap to better patient care.
    Catheter Cardiovasc Interv. 2021;97:94-96.
    PubMed     Abstract available


  204. FAN LM, Tong D, Mintz GS, Mamas MA, et al
    Breaking the deadlock of calcified coronary artery lesions: A contemporary review.
    Catheter Cardiovasc Interv. 2021;97:108-120.
    PubMed     Abstract available


  205. DI MARCO A, Anguera I, Nombela-Franco L, Oloriz T, et al
    Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Catheter Cardiovasc Interv. 2021;97:E1-E11.
    PubMed     Abstract available


  206. MCQUILLAN C, Jackson MWP, Brilakis ES, Egred M, et al
    Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI.
    Catheter Cardiovasc Interv. 2021;97:121-126.
    PubMed     Abstract available


  207. BABER U, Chandiramani R, Mehta SR, Sartori S, et al
    Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
    Catheter Cardiovasc Interv. 2021;97:63-71.
    PubMed     Abstract available


  208. KUME T, Murasato Y, Yamada R, Koyama T, et al
    Effect of proximal balloon edge dilation technique for opening a side branch ostium in repetitive-proximal optimizing technique sequence.
    Catheter Cardiovasc Interv. 2021;97:E12-E18.
    PubMed     Abstract available


  209. CHEN K, Scridon T, Chait R
    Inadvertent aortocoronary arteriovenous fistula after CABG: Systematic review of case reports.
    Catheter Cardiovasc Interv. 2021;97:E19-E25.
    PubMed     Abstract available


  210. AZZALINI L, Alaswad K, Uretsky BF, Agostoni P, et al
    Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2021;97:E40-E50.
    PubMed     Abstract available


  211. LAMELAS P, Padilla L, Abud M, Cigalini I, et al
    In-stent chronic total occlusion angioplasty in the LATAM-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:E34-E39.
    PubMed     Abstract available


  212. MOROFUJI T, Kuramitsu S, Shinozaki T, Jinnouchi H, et al
    Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:10-19.
    PubMed     Abstract available


  213. WIEBE J, Hofmann FJ, Dorr O, Bauer T, et al
    Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Catheter Cardiovasc Interv. 2021;97:56-62.
    PubMed     Abstract available


  214. NEUPANE S, Basir M, Tan C, Sultan A, et al
    Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
    Catheter Cardiovasc Interv. 2021;97:2-7.
    PubMed     Abstract available


    December 2020
  215. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  216. BLOOM JE, Dinh DT, Noaman S, Martin C, et al
    Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29436.
    PubMed     Abstract available


  217. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  218. TOKUDA T, Mori S, Oba Y, Koshida R, et al
    Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2020 Dec 12. doi: 10.1002/ccd.29437.
    PubMed     Abstract available


  219. ASIF A, Sezer A, Thoma F, Toma C, et al
    Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary interv
    Catheter Cardiovasc Interv. 2020 Dec 9. doi: 10.1002/ccd.29399.
    PubMed     Abstract available


    November 2020
  220. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  221. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  222. BLUM M, Cao D, Chandiramani R, Goel R, et al
    Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29402.
    PubMed     Abstract available


  223. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  224. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  225. KAWASHIMA H, Hara H, Wang R, Ono M, et al
    Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29383.
    PubMed     Abstract available


  226. SHAH S, Castro-Dominguez Y, Gupta T, Attaran R, et al
    Impact of the COVID-19 pandemic on interventional cardiology training in the United States.
    Catheter Cardiovasc Interv. 2020;96:997-1005.
    PubMed     Abstract available


  227. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  228. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    PubMed    


    October 2020
  229. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  230. SOGA Y, Takahara M, Ito N, Katsuki T, et al
    Clinical impact of intravascular ultrasound-guided balloon angioplasty in patients with chronic limb threatening ischemia for isolated infrapopliteal lesion.
    Catheter Cardiovasc Interv. 2020 Oct 21. doi: 10.1002/ccd.29347.
    PubMed     Abstract available


  231. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  232. SEPULVEDA P, Hameau R, Backhouse C, Charme G, et al
    Mid-term follow-up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29322.
    PubMed     Abstract available


  233. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed     Abstract available


  234. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    PubMed     Abstract available


  235. COLOMBO A, Laricchia A
    Removing the plaque and implanting a drug-eluting stent: The way to success.
    Catheter Cardiovasc Interv. 2020;96:782-783.
    PubMed    


  236. DANGAS G, Khan AA
    Rolling the rock uphill during left main stenting: The Sisyphus myth in percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2020;96:762-763.
    PubMed    


  237. WHITESIDE HL, Moliterno DJ
    Coronary interventions among patients with hepatic insufficiency: Encouragement to avoid a jaundiced view.
    Catheter Cardiovasc Interv. 2020;96:811-812.
    PubMed    


  238. GRINES CL, Tummala P
    Another nail in the coffin for the use of risk-adjusted mortality after percutaneous coronary intervention as a quality indicator.
    Catheter Cardiovasc Interv. 2020;96:741-742.
    PubMed    


  239. GOLDSTEIN JA, Dixon SR
    Mechanically supported PCI for ischemic cardiomyopathy reawakening of hibernating myocardium.
    Catheter Cardiovasc Interv. 2020;96:771-772.
    PubMed    


    September 2020
  240. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  241. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    PubMed     Abstract available


  242. BENGALURU JAYANNA M, Gray WA
    Applied pharmacology in percutaneous coronary intervention: You can't fight mother nature.
    Catheter Cardiovasc Interv. 2020;96:565-566.
    PubMed     Abstract available


  243. BELARDI JA, Lamelas PM
    Gender disparities in high-risk angioplasty: Still room for improvement.
    Catheter Cardiovasc Interv. 2020;96:545-546.
    PubMed    


  244. MUSUMECI G, Annibali G
    Upstream anticoagulation: Another brick in the wall?
    Catheter Cardiovasc Interv. 2020;96:526-527.
    PubMed    


  245. RODRIGUEZ-PAZ E, Heuser RR
    A new perspective in CTO PCI.
    Catheter Cardiovasc Interv. 2020;96:577.
    PubMed    


  246. JHA A, Ahmed M
    An emerging use of the Swan-Ganz catheter: Pulmonary artery catheter delivered thrombolysis in massive pulmonary embolism.
    Catheter Cardiovasc Interv. 2020;96:728-729.
    PubMed    


  247. LOPERA JE, Jen S
    Superior vena cava filter placement over existing central venous lines: Is line removal necessary?
    Catheter Cardiovasc Interv. 2020;96:651-656.
    PubMed     Abstract available


  248. TANNOUS P, Popescu A, Forbess L, Nugent A, et al
    Transcatheter biventricular conversion in an adult patient with a 1.5 ventricle Glenn palliation and superior vena cava syndrome.
    Catheter Cardiovasc Interv. 2020;96:633-637.
    PubMed     Abstract available


  249. MATHIS C, Romans R, Divekar A
    Variation in the outer diameter of vascular sheaths commonly used in infant cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;96:620-625.
    PubMed     Abstract available


  250. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  251. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    PubMed     Abstract available


  252. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed     Abstract available


  253. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    PubMed     Abstract available


  254. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    PubMed     Abstract available


  255. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    PubMed     Abstract available


  256. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed     Abstract available


  257. PROMPHAN W, Han Siang K, Prachasilchai P, Jarutach J, et al
    Feasibility and early outcomes of aortic coarctation treatments with BeGraft Aortic stent.
    Catheter Cardiovasc Interv. 2020;96:E310-E316.
    PubMed     Abstract available


  258. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    PubMed     Abstract available


  259. GALLONE G, D'Ascenzo F, Boccuzzi G, Cortese B, et al
    Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Catheter Cardiovasc Interv. 2020;96:E248-E256.
    PubMed     Abstract available


  260. KOREN O, Abu Rajab Saaida R, Rozner E, Turgeman Y, et al
    Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).
    Catheter Cardiovasc Interv. 2020;96:E317-E323.
    PubMed     Abstract available


  261. SONCK J, Collet C, Mizukami T, Vandeloo B, et al
    Motorized fractional flow reserve pullback: Accuracy and reproducibility.
    Catheter Cardiovasc Interv. 2020;96:E230-E237.
    PubMed     Abstract available


  262. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    PubMed     Abstract available


  263. RADHOE SP, Schuurman AS, Ligthart JM, Witberg K, et al
    Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Catheter Cardiovasc Interv. 2020;96:E204-E212.
    PubMed     Abstract available


  264. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    PubMed     Abstract available


    August 2020
  265. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    PubMed     Abstract available


  266. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  267. BOM MJ, Schumacher SP, Driessen RS, van Diemen PA, et al
    Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29210.
    PubMed     Abstract available


  268. NAIDU SS, Coylewright M, Hawkins BM, Meraj P, et al
    Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank.
    Catheter Cardiovasc Interv. 2020 Aug 25. doi: 10.1002/ccd.29197.
    PubMed     Abstract available


  269. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    PubMed     Abstract available


  270. SAGLIETTO A, D'Ascenzo F, Errigo D, Leonardi S, et al
    Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29192.
    PubMed     Abstract available


  271. TEDESCHI D, Rizzi A, Biscaglia S, Tumscitz C, et al
    Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29179.
    PubMed     Abstract available


  272. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    PubMed     Abstract available


  273. POSTALIAN A, Krajcer Z
    Transradial versus transfemoral access: The dispute continues.
    Catheter Cardiovasc Interv. 2020;96:296-297.
    PubMed    


  274. BUTMAN SM
    Radial artery intervention: Facile for you is best for me, too.
    Catheter Cardiovasc Interv. 2020;96:274-275.
    PubMed     Abstract available


  275. ASHLEY KE, Hillegass WB
    Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;96:309-310.
    PubMed    


  276. CHANDRASEKHAR J, Dangas G, Baber U, Sartori S, et al
    Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.
    Catheter Cardiovasc Interv. 2020;96:298-308.
    PubMed     Abstract available


  277. BENEDUCE A, Ferrante G, Ielasi A, Pivato CA, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
    Catheter Cardiovasc Interv. 2020;96:255-265.
    PubMed     Abstract available


  278. BAYON J, Santas-Alvarez M, Ocaranza-Sanchez R, Gonzalez-Juanatey C, et al
    Magmaris very late in-scaffold restenosis: Has the "black boxes" nightmare come back?
    Catheter Cardiovasc Interv. 2020;96:E174-E176.
    PubMed     Abstract available


  279. XI Y, Chen J, Bi Y, Xie S, et al
    Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Catheter Cardiovasc Interv. 2020;96:E129-E141.
    PubMed     Abstract available


  280. BRIGUORI C, Tamburino C, Jessurun GAJ, Meyer-Gessner M, et al
    Prospective evaluation of drug eluting self-apposing stent for the treatment of unprotected left main coronary artery disease: 1-year results of the TRUNC study.
    Catheter Cardiovasc Interv. 2020;96:E142-E148.
    PubMed     Abstract available


  281. PLOUMEN EH, Buiten RA, Kok MM, Doggen CJM, et al
    Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Catheter Cardiovasc Interv. 2020;96:E110-E118.
    PubMed     Abstract available


  282. KWON O, Lee JB, Ahn JM, Kang SJ, et al
    Clinical outcomes of contemporary drug-eluting stents in patients with and without diabetes mellitus: Multigroup propensity-score analysis using data from stent-specific, multicenter, prospective registries.
    Catheter Cardiovasc Interv. 2020;96:243-252.
    PubMed     Abstract available


  283. GEORGE JC, Tabaza L, Janzer S
    Robotic-assisted balloon angioplasty and stent placement with distal embolic protection device for severe carotid artery stenosis in a high-risk surgical patient.
    Catheter Cardiovasc Interv. 2020;96:410-412.
    PubMed     Abstract available


  284. QIU Z, Liu J, Huang R, Liu D, et al
    Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Catheter Cardiovasc Interv. 2020;96:404-409.
    PubMed     Abstract available


  285. YAN C, Wan L, Li L, Li H, et al
    Transfemoral transcatheter puncture of interventricular septum in a swine model: A novel transfemoral-venous access to left ventricle with the assistance of arterio-venous circuit.
    Catheter Cardiovasc Interv. 2020;96:488-496.
    PubMed     Abstract available


  286. BUNCH F, Nair P, Aggarwala G, Dippel E, et al
    A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.
    Catheter Cardiovasc Interv. 2020;96:393-401.
    PubMed     Abstract available


  287. SIVAKUMAR K, Anantharaj A, Raghuram P, Krishna Kumar R, et al
    First in man study of a new semi-open cell design Zephyr cobalt-chromium stent in large vessels and conduits.
    Catheter Cardiovasc Interv. 2020;96:367-375.
    PubMed     Abstract available


  288. BARBASH IM, Kornowski R, Berkovitch A, Assali A, et al
    Percutaneous nitinol-based vascular closure device for large bore arterial access hemostasis: Results of a prospective multicenter study.
    Catheter Cardiovasc Interv. 2020;96:473-478.
    PubMed     Abstract available


  289. GUREVICH S, Prins KW
    The evolving role of interventional cardiology in the treatment of pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 1. doi: 10.1002/ccd.29146.
    PubMed     Abstract available


    July 2020
  290. SHAH H, Ramineni G, Varghese R, Thwe EE, et al
    Outcomes of percutaneous coronary interventions in patients with liver transplant.
    Catheter Cardiovasc Interv. 2020 Jul 29. doi: 10.1002/ccd.29168.
    PubMed     Abstract available


  291. SIUDAK Z, Grygier M, Wojakowski W, Malinowski KP, et al
    Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2020 Jul 20. doi: 10.1002/ccd.29134.
    PubMed     Abstract available


  292. POPOVIC B, Varlot J, Metzdorf PA, Jeulin H, et al
    Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection.
    Catheter Cardiovasc Interv. 2020 Jul 15. doi: 10.1002/ccd.29114.
    PubMed     Abstract available


  293. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  294. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    PubMed     Abstract available


  295. BUTMAN SM
    Revascularization for multivessel disease: Getting closer, but....
    Catheter Cardiovasc Interv. 2020;96:52.
    PubMed     Abstract available


  296. GRINES CL, Cox D
    Can percutaneous coronary interventions be performed safely in leukemia patients?
    Catheter Cardiovasc Interv. 2020;96:64-65.
    PubMed     Abstract available


  297. HERING D, Heuser RR
    Belt and suspenders: Why it pays to protect and cover during carotid stenting.
    Catheter Cardiovasc Interv. 2020;96:128.
    PubMed     Abstract available


  298. COSTELLO B, Krajcer Z
    Assessing atherothrombotic burden with optical coherence tomography analysis may facilitate post-PCI prognostication and antiplatelet therapy.
    Catheter Cardiovasc Interv. 2020;96:98-99.
    PubMed     Abstract available


  299. SRIDHARAN A, Kimmelstiel C
    Morphine in primary percutaneous coronary intervention-No pain, questionable gain.
    Catheter Cardiovasc Interv. 2020;96:89-90.
    PubMed     Abstract available


  300. CHENEY A, Dean LS
    State-of-the-art percutaneous coronary interventions applied to the treatment of bifurcation lesions: Are we there yet?
    Catheter Cardiovasc Interv. 2020;96:18-19.
    PubMed     Abstract available


  301. ARANZULLA TC, Musumeci G
    True caring is protecting who is at your side.
    Catheter Cardiovasc Interv. 2020;96:29-30.
    PubMed     Abstract available


  302. BACK SH, Gray WA
    Peripheral vascular disease in women: Are we analyzing the costs correctly?
    Catheter Cardiovasc Interv. 2020;96:143-144.
    PubMed     Abstract available


  303. PICCOLO R, Esposito G
    Ticagrelor monotherapy in patients undergoing percutaneous coronary intervention for bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:112-113.
    PubMed     Abstract available


  304. ZIMARINO M, Barbato E, Nakamura S, Radico F, et al
    The impact of the extent of side branch disease on outcomes following bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:E84-E92.
    PubMed     Abstract available


  305. SHISHIDO K, Moriyama N, Hayashi T, Yokota S, et al
    The efficacy of modified jailed balloon technique for true bifurcation lesions.
    Catheter Cardiovasc Interv. 2020;96:20-28.
    PubMed     Abstract available


  306. ANDREASEN LN, Holm NR, Webber B, Ormiston JA, et al
    Critical aspects of balloon position during final proximal optimization technique (POT) in coronary bifurcation stenting.
    Catheter Cardiovasc Interv. 2020;96:31-39.
    PubMed     Abstract available


  307. AMOROSO G, van der Brug S, Franx V, van Dullemen A, et al
    Slender versus conventional approach reduces post-procedural upper extremity dysfunction after transradial coronary procedures.
    Catheter Cardiovasc Interv. 2020;96:66-73.
    PubMed     Abstract available


  308. SZERLIP M, Feldman DN, Aronow HD, Blankenship JC, et al
    SCAI publications committee manual of standard operating procedures.
    Catheter Cardiovasc Interv. 2020;96:145-155.
    PubMed     Abstract available


  309. IANNACCONE M, D'Ascenzo F, Gallone G, Mitomo S, et al
    Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes.
    Catheter Cardiovasc Interv. 2020;96:1-9.
    PubMed     Abstract available


  310. GRAY WA, Levy E, Bacharach JM, Metzger DC, et al
    Evaluation of a novel mesh-covered stent for treatment of carotid stenosis in patients at high risk for endarterectomy: 1-year results of the SCAFFOLD trial.
    Catheter Cardiovasc Interv. 2020;96:121-127.
    PubMed     Abstract available


  311. KUMAR K, Reddy S, Acharya D, Lotun K, et al
    Novel technique of performing multivessel PCI through an Impella sheath.
    Catheter Cardiovasc Interv. 2020;96:117-120.
    PubMed     Abstract available


  312. WOLLMUTH J, Korngold E, Croce K, Pinto DS, et al
    The Single-access for Hi-risk PCI (SHiP) technique.
    Catheter Cardiovasc Interv. 2020;96:114-116.
    PubMed     Abstract available


  313. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  314. VO MN, Brilakis ES, Pershad A, Grantham JA, et al
    Modified subintimal transcatheter withdrawal: A novel technique for hematoma decompression to facilitate distal reentry during coronary chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2020;96:E98-E101.
    PubMed     Abstract available


  315. LIU J, Li L, Chen C, Wei J, et al
    Modified kissing balloon inflation associated with better results after Culotte stenting for bifurcation lesions: A bench test.
    Catheter Cardiovasc Interv. 2020;96:E34-E44.
    PubMed     Abstract available


  316. KATSIKIS A, Keeble TR, Davies JR, Jagathesan R, et al
    Contemporary management of stent thrombosis: Predictors of mortality and the role of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2020;96:E8-E16.
    PubMed     Abstract available


  317. CERRATO E, Barbero U, Quadri G, Ryan N, et al
    Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III st
    Catheter Cardiovasc Interv. 2020;96:E17-E26.
    PubMed     Abstract available


  318. CHAN YH, Cheng VYH, Wong CW, Lam CS, et al
    A simplified reverse wire technique using an angulated supercross microcatheter.
    Catheter Cardiovasc Interv. 2020;96:E93-E97.
    PubMed     Abstract available


  319. CASANA R, Tolva VS, Odero A Jr, Malloggi C, et al
    Carotid artery stenting is safe and effective for symptomatic patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020;96:129-135.
    PubMed     Abstract available


  320. MODOLO R, Kogame N, Komiyama H, Chichareon P, et al
    Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study.
    Catheter Cardiovasc Interv. 2020;96:10-17.
    PubMed     Abstract available


    June 2020
  321. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    PubMed     Abstract available


  322. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    PubMed    


  323. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    PubMed     Abstract available


  324. CHUGH Y, Bavishi C, Mojadidi MK, Elgendy IY, et al
    Safety of transradial access compared to transfemoral access with hemostatic devices (vessel plugs and suture devices) after percutaneous coronary interventions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.29061.
    PubMed     Abstract available


  325. KARACSONYI J, Brilakis ES
    Percutaneous coronary intervention: The "oculosufficient" effect and how to overcome it.
    Catheter Cardiovasc Interv. 2020;95:1267-1268.
    PubMed     Abstract available


  326. GRINES CL, Tummala P, Marshall JJ
    STEMI in the cancer patient: Do not withhold primary PCI!
    Catheter Cardiovasc Interv. 2020;95:1275-1276.
    PubMed     Abstract available


  327. CLEGG S, Blankenship JC
    Post-dilatation trepidation: Post-dil is "no big dil".
    Catheter Cardiovasc Interv. 2020;95:1257-1258.
    PubMed     Abstract available


  328. MELNICK G, Ferrone M, Cheng Y, Conditt GB, et al
    Long-term performance and biocompatibility of a novel bioresorbable scaffold for peripheral arteries: A three-year pilot study in Yucatan miniswine.
    Catheter Cardiovasc Interv. 2020;95:1277-1284.
    PubMed     Abstract available


  329. TANASE D, Georgiev S, Eicken A, Ewert P, et al
    Transcatheter creation of bidirectional cavopulmonary connections by needle punctures in two patients.
    Catheter Cardiovasc Interv. 2020;95:1305-1309.
    PubMed     Abstract available


  330. NAKAMA T, Obunai K, Muraishi M, Watanabe H, et al
    Percutaneous endoluminal anatomical bypass for patients with external iliac artery occlusion after failed conventional endovascular recanalization.
    Catheter Cardiovasc Interv. 2020;95:1320-1326.
    PubMed     Abstract available


  331. MEMON S, Janzer S, Kalra S, George JC, et al
    Recanalization of superior mesenteric artery chronic total occlusion using hybrid algorithm and dissection reentry device.
    Catheter Cardiovasc Interv. 2020;95:1314-1319.
    PubMed     Abstract available


  332. SAITO S, Ikeda N, Toi S, Nakamura M, et al
    Gadolinium contrast balloon pulmonary angioplasty for a patient with chronic thromboembolic pulmonary hypertension and severe iodine allergy.
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29004.
    PubMed     Abstract available


  333. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    PubMed     Abstract available


    May 2020
  334. SEIF S, Ayuna A, Kumar A, Macdonald J, et al
    Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.29050.
    PubMed     Abstract available


  335. ELEID MF, Zheng PP, Gulati R, Bergman P, et al
    Remote robotic percutaneous coronary intervention: An animal feasibility study.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28978.
    PubMed     Abstract available


  336. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed     Abstract available


  337. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  338. EFFOE VS, Kumar G, Sachdeva R
    Intravascular ultrasound-guided pulmonary artery embolectomy for saddle pulmonary embolism.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28985.
    PubMed     Abstract available


  339. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  340. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  341. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  342. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    PubMed     Abstract available


  343. VIRK HUH, Lakhter V, Tabaza L, George JC, et al
    Do we need robotics for coronary intervention more than ever in the COVID-19 era?
    Catheter Cardiovasc Interv. 2020 May 7. doi: 10.1002/ccd.28949.
    PubMed    


  344. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


  345. OOI YS, Gray WA
    Taking the kidney to heart.
    Catheter Cardiovasc Interv. 2020;95:1122-1123.
    PubMed     Abstract available


  346. CHIARITO M, Mehran R
    Panta rhei, also drug eluting stent technology.
    Catheter Cardiovasc Interv. 2020;95:1074-1075.
    PubMed     Abstract available


  347. TOMMASO CL
    Stenting in unprotected left main coronary stenosis-"What no progress"?
    Catheter Cardiovasc Interv. 2020;95:1092-1093.
    PubMed     Abstract available


  348. SHATILA W, Krajcer Z
    Thoracic aortic disease: Can we safely cover the branches?
    Catheter Cardiovasc Interv. 2020;95:1169-1170.
    PubMed     Abstract available


  349. BAI J, Liu Y, Jin J, Wu J, et al
    Mid-term results of in situ fenestration stented with balloon-expandable bare metal stents during thoracic endovascular aortic repair.
    Catheter Cardiovasc Interv. 2020;95:1163-1168.
    PubMed     Abstract available


  350. SMITH CL, Saul D, Goldfarb SB, Biko DM, et al
    Compression of the left mainstem bronchus by patent ductus arteriosus in neonates under consideration for ductal stenting.
    Catheter Cardiovasc Interv. 2020;95:1158-1162.
    PubMed     Abstract available


  351. ONO S, Shimogawara T, Yamazoe S, Matsui J, et al
    Successful endovascular isolation of a huge true anterior tibial artery aneurysm by the bi-directional approach in a young patient.
    Catheter Cardiovasc Interv. 2020;95:E175-E178.
    PubMed     Abstract available


  352. HAUDE M, Lee SWL, Worthley SG, Silber S, et al
    The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
    Catheter Cardiovasc Interv. 2020;95:1076-1084.
    PubMed     Abstract available


  353. VAN ZANDVOORT LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, et al
    Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2020;95:1085-1091.
    PubMed     Abstract available


    April 2020
  354. XIAO Z, Xu C, Wang D, Zeng H, et al
    The experience of treating patients with acute myocardial infarction under the COVID-19 epidemic.
    Catheter Cardiovasc Interv. 2020 Apr 29. doi: 10.1002/ccd.28951.
    PubMed     Abstract available


  355. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  356. SADEGHIPOUR P, Talasaz AH, Eslami V, Gerayeli B, et al
    Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889.
    PubMed     Abstract available


  357. MAHMUD E, Dauerman HL, Welt FG, Messenger JC, et al
    Management of Acute Myocardial Infarction During the COVID-19 Pandemic.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28946.
    PubMed     Abstract available


  358. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  359. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  360. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  361. MEGALY M, Brilakis ES
    Telesupported procedures: when and how.
    Catheter Cardiovasc Interv. 2020;95:911-913.
    PubMed     Abstract available


  362. KATARUKA A, Dean LS
    Uncommon but devastating: Stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;95:893-894.
    PubMed     Abstract available


  363. MUSUMECI G, Baralis G
    Coronary total occlusion and minimalist approach: When less is more.
    Catheter Cardiovasc Interv. 2020;95:E150-E151.
    PubMed    


  364. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  365. SHAH AH, Osten M, Benson L, Alnasser S, et al
    Long-term outcomes of percutaneous closure of coronary artery fistulae in the adult: A single-center experience.
    Catheter Cardiovasc Interv. 2020;95:939-948.
    PubMed     Abstract available


  366. FENDER EA, Widmer RJ, Mahowald MK, Hodge DO, et al
    Recurrent pulmonary vein stenosis after successful intervention: Prognosis and management of restenosis.
    Catheter Cardiovasc Interv. 2020;95:954-958.
    PubMed     Abstract available


  367. MADDER RD, VanOosterhout S, Mulder A, Bush J, et al
    Network latency and long-distance robotic telestenting: Exploring the potential impact of network delays on telestenting performance.
    Catheter Cardiovasc Interv. 2020;95:914-919.
    PubMed     Abstract available


  368. SALAHUDDIN S, Faizal A, Koshy S, Moideen Koya M, et al
    An unusual shot-retrograde transthoraco-abdominal venous bullet embolization.
    Catheter Cardiovasc Interv. 2020;95:978-981.
    PubMed     Abstract available


  369. ADACHI T, Sato A, Kuroki K, Terai T, et al
    Audiovisual telesupport system for cardiovascular catheter interventions: A preliminary report on the clinical implications.
    Catheter Cardiovasc Interv. 2020;95:906-910.
    PubMed     Abstract available


  370. MAZZACCARO D, Castronovo EL, Righini P, Nano G, et al
    Use of steerable catheters for endovascular procedures: Report of a CASE and literature review.
    Catheter Cardiovasc Interv. 2020;95:971-977.
    PubMed     Abstract available


  371. YANG HM, Lim HS, Yoon MH, Seo KW, et al
    Usefulness of the trans-stent fractional flow reserve gradient for predicting clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:E123-E129.
    PubMed     Abstract available


  372. WIPER A, Amoroso G, Rao S, Nolan J, et al
    Complex regional pain syndrome: A rare but potentially disabling complication of transradial cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;95:E140-E143.
    PubMed     Abstract available


    March 2020
  373. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  374. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    PubMed     Abstract available


  375. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  376. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    PubMed     Abstract available


  377. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  378. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  379. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    PubMed     Abstract available


  380. MANNING P, Abbott JD
    Radial access: So much progress but a way to go.
    Catheter Cardiovasc Interv. 2020;95:684-685.
    PubMed     Abstract available


  381. KRAJCER Z, Costello BT
    Editorial for: Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes.
    Catheter Cardiovasc Interv. 2020;95:765-766.
    PubMed     Abstract available


  382. GRINES CL, Marshall JJ
    Invasive imaging of myocardial infarction patients: Is less or more better?
    Catheter Cardiovasc Interv. 2020;95:704-705.
    PubMed     Abstract available


  383. RIANGWIWAT T, Blankenship JC
    Side branches don't get respect.
    Catheter Cardiovasc Interv. 2020;95:694-695.
    PubMed    


  384. DE GREGORIO J, Bailey SR
    ISCHEMIA from a clinicians perspective: Treating the patient or the investigator?
    Catheter Cardiovasc Interv. 2020;95:711-712.
    PubMed    


  385. DROUVEN JW, de Bruin C, van Roon AM, Oldenziel J, et al
    Outcomes after endovascular mechanical thrombectomy in occluded vascular access used for dialysis purposes.
    Catheter Cardiovasc Interv. 2020;95:758-764.
    PubMed     Abstract available


  386. KOKKINIDIS DG, Strobel A, Jawaid O, Haider MN, et al
    Development and validation of a predictive score for anterograde crossing of infrapopliteal chronic total occlusions: (The Infrapop-CTO Score).
    Catheter Cardiovasc Interv. 2020;95:748-755.
    PubMed     Abstract available


  387. KARAHALIOS B, Rojas SF, Singh R, Cavazos MC, et al
    Torque device suture technique to achieve hemostasis in large-bore venous access.
    Catheter Cardiovasc Interv. 2020;95:722-725.
    PubMed     Abstract available


  388. BAUSER-HEATON H, Qureshi AM, Goldstein BH, Glatz AC, et al
    Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborative.
    Catheter Cardiovasc Interv. 2020;95:726-733.
    PubMed     Abstract available


  389. ORR WB, Johnson MC, Abarbanell AM, Sintek M, et al
    Recanalization of an atretic intramural left main coronary artery after bypass surgery in a pediatric patient with anomalous aortic origin of the left main coronary artery arising from the right sinus of Valsalva.
    Catheter Cardiovasc Interv. 2020;95:739-742.
    PubMed     Abstract available


  390. SORENSEN MW, Bauser-Heaton H, Petit CJ
    Percutaneous paraspinal access to the azygos vein to create a neo-vena cava.
    Catheter Cardiovasc Interv. 2020;95:734-738.
    PubMed     Abstract available


  391. ABDUL JABBAR A, Chanda A, White CJ, Jenkins JS, et al
    Percutaneous endovascular abdominal aneurysm repair: State-of-the art.
    Catheter Cardiovasc Interv. 2020;95:767-782.
    PubMed     Abstract available


  392. WANG Z, Wang C, Li F, Zhao Y, et al
    Endovascular repair during complex thoracic aortic dissection using a micropore stent graft: Midterm follow-up clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:E111-E119.
    PubMed     Abstract available


  393. RAGHUNATHAN D, Hernandez N, Rajagopal K, Jumean M, et al
    Axillary Impella insertion under regional nerve block: A case report.
    Catheter Cardiovasc Interv. 2020;95:E108-E110.
    PubMed     Abstract available


  394. MIRANDA WR, Hagler DJ, Taggart NW, Borlaug BA, et al
    Elevated ventricular filling pressures and long-term survival in adults post-Fontan.
    Catheter Cardiovasc Interv. 2020;95:803-809.
    PubMed     Abstract available


  395. CHESTER RC, Mina SA, Lewis B, Zhang N, et al
    Radial artery access is under-utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry.
    Catheter Cardiovasc Interv. 2020;95:675-683.
    PubMed     Abstract available


    February 2020
  396. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    PubMed     Abstract available


  397. HUDED CP, Kapadia SR, Ballout JA, Krishnaswamy A, et al
    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28785.
    PubMed     Abstract available


  398. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  399. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  400. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available


  401. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  402. TOPAZ O
    PEI for allograft renal artery stenosis: a unique role and broad implications for renal artery stenosis treatment.
    Catheter Cardiovasc Interv. 2020;95:437-438.
    PubMed    


  403. YILDIZ M, Henry TD
    Preprocedure Thrombolysis In Myocardial Infarction (TIMI) flow grade: Has its time come and gone?
    Catheter Cardiovasc Interv. 2020;95:501-502.
    PubMed    


  404. AYYOUB A, Levy MS
    Mechanical circulatory support in high-risk percutaneous coronary intervention: IIb or not IIb?
    Catheter Cardiovasc Interv. 2020;95:513-514.
    PubMed    


  405. MUSTAPHA JA, Saab F, McGoff TN, Adams G, et al
    Tibiopedal arterial minimally invasive retrograde revascularization (TAMI) in patients with peripheral arterial disease and critical limb ischemia. On behalf of the Peripheral Registry of Endovascular Clinical Outcomes (PRIME).
    Catheter Cardiovasc Interv. 2020;95:447-454.
    PubMed     Abstract available


  406. KOKKINIDIS DG, Behan S, Jawaid O, Hossain P, et al
    Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Catheter Cardiovasc Interv. 2020;95:439-446.
    PubMed     Abstract available


  407. REN Y, Xiong F, Kan X, Qian K, et al
    Endovascular management of transplant renal artery stenosis: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2020;95:429-436.
    PubMed     Abstract available


  408. SUNTHAROS P, Worley SE, Liu W, Siperstein M, et al
    Long-term outcome of percutaneous intervention for pulmonary vein stenosis after pulmonary vein isolation procedure.
    Catheter Cardiovasc Interv. 2020;95:389-397.
    PubMed     Abstract available


  409. MASCHIETTO N, Baird C, Porras D
    Percutaneous intraluminal downsizing of systemic-to-pulmonary artery shunts: a novel application of the Diabolo stent technique-Case series and description of the technique.
    Catheter Cardiovasc Interv. 2020;95:471-476.
    PubMed     Abstract available


  410. HIREMATH G, Morgan G, Kenny D, Batlivala SP, et al
    Balloon expandable covered stents as primary therapy for hemodynamically stable traumatic aortic injuries in children.
    Catheter Cardiovasc Interv. 2020;95:477-483.
    PubMed     Abstract available


  411. MOUSSA PACHA H, Al-Khadra Y, Darmoch F, Soud M, et al
    In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients.
    Catheter Cardiovasc Interv. 2020;95:E84-E95.
    PubMed     Abstract available


  412. D'ASCENZO F, Gaido L, Bernardi A, Saglietto A, et al
    Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
    Catheter Cardiovasc Interv. 2020;95:522-529.
    PubMed     Abstract available


  413. ROSSEEL L, De Backer O, Sondergaard L, Bieliauskas G, et al
    Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair.
    Catheter Cardiovasc Interv. 2020;95:E96-E99.
    PubMed     Abstract available


  414. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    PubMed     Abstract available


  415. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available


  416. MUSUMECI G, Baralis G
    Bioresorbable scaffold: Never say never.
    Catheter Cardiovasc Interv. 2020;95:224-225.
    PubMed     Abstract available


  417. BIENEK S, Kusmierczuk M, Mittag A, Bettink S, et al
    Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
    Catheter Cardiovasc Interv. 2020;95:319-328.
    PubMed     Abstract available


  418. KIESZ RS, Gora B, Kolarczyk-Haczyk A, Kachel M, et al
    Clinical significance of mirror lesions in lower extremity arterial disease.
    Catheter Cardiovasc Interv. 2020;95:300-306.
    PubMed     Abstract available


  419. SMITH CL, Hoffman TM, Dori Y, Rome JJ, et al
    Decompression of the thoracic duct: A novel transcatheter approach.
    Catheter Cardiovasc Interv. 2020;95:E56-E61.
    PubMed     Abstract available


  420. IANNACCONE M, Colangelo S, Colombo F, Garbo R, et al
    Rotational atherectomy with the new RotaPro system over RG3 guidewire in subadventitial retrograde highly calcified CTO PCI.
    Catheter Cardiovasc Interv. 2020;95:242-244.
    PubMed     Abstract available


  421. TABAZA L, Janzer S, George JC
    Stent crush: A novel endovascular approach for treatment of complex in-stent femoropopliteal chronic total occlusion.
    Catheter Cardiovasc Interv. 2020;95:E66-E70.
    PubMed     Abstract available


  422. FORD TJ, Khan A, Docherty KF, Jackson A, et al
    Sex differences in procedural and clinical outcomes following rotational atherectomy.
    Catheter Cardiovasc Interv. 2020;95:232-241.
    PubMed     Abstract available


  423. INIGUEZ A, Chevalier B, Richardt G, Neylon A, et al
    Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized cli
    Catheter Cardiovasc Interv. 2020;95:175-184.
    PubMed     Abstract available


  424. GOEL S, Pasam RT, Chava S, Sharma A, et al
    Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.
    Catheter Cardiovasc Interv. 2020;95:216-223.
    PubMed     Abstract available


  425. JIA S, Guan C, Yuan J, Cao X, et al
    Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort.
    Catheter Cardiovasc Interv. 2020;95:206-215.
    PubMed     Abstract available


  426. CORTESE B, Alfonso F, Pellegrini D, Sing KR, et al
    The hypothesis of an increased mortality following paclitaxel coated device use in peripheral vascular interventions (and the emerging era of meta-analysis based evidence).
    Catheter Cardiovasc Interv. 2020;95:329-331.
    PubMed    


  427. GAO R, Xu B
    CCI and CIT 2020-A special year of the special issue.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:532-533.
    PubMed    


  428. BAILEY SR
    CCI 2020 CIT special issue.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:531.
    PubMed    


  429. LIU Y, Zhang Y, Li Y, Qi T, et al
    One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:658-664.
    PubMed     Abstract available


  430. WANG G, Ma G, Tao L, Yuan Z, et al
    Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:565-571.
    PubMed     Abstract available


  431. TIAN J, Tang YD, Qiao S, Su X, et al
    Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:587-597.
    PubMed     Abstract available


  432. CHEN Y, Dong H, Jiang X, Deng Y, et al
    Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:641-647.
    PubMed     Abstract available


  433. ZHAO X, Guan C, Yuan J, Xie L, et al
    A modified predilation, sizing, and postdilation scoring system for patients undergoing metallic drug-eluting stent implantations.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:558-564.
    PubMed     Abstract available


  434. CHE W, Dong H, Jiang X, Xiong H, et al
    The effect of stenting on blood pressure in hypertensive patients with symptomatic proximal subclavian or vertebral artery stenosis.
    Catheter Cardiovasc Interv. 2020;95 Suppl 1:633-640.
    PubMed     Abstract available


    January 2020
  435. MAHMUD E
    The COMPLETE and ISCHEMIA trials: Two contemporary studies showing percutaneous coronary intervention reduces the risk of myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 29. doi: 10.1002/ccd.28723.
    PubMed    


  436. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  437. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    PubMed     Abstract available


  438. TYLER JM, Henry TD
    Intraaortic balloon pump in myocardial infarction: Always, Never, or for the Right Patient?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28683.
    PubMed     Abstract available


  439. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  440. GILCHRIST IC
    Gastrointestinal bleeding after percutaneous coronary intervention: Not just a short-term complication but a long-term marker of mortality risk.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28680.
    PubMed     Abstract available


  441. YOU J, Li H, Guo W, Li J, et al
    Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28712.
    PubMed     Abstract available


  442. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  443. XU MX, Ruddy TD, Schoenhagen P, Bartel T, et al
    The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: A proof-of-concept study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28724.
    PubMed     Abstract available


  444. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  445. SHAO C, Wang J, Li P, Yang J, et al
    Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28706.
    PubMed     Abstract available


  446. ZHAO X, Li J, Xian Y, Chen J, et al
    Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28719.
    PubMed     Abstract available


  447. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  448. SHENG X, Qiao Z, Ge H, Sun J, et al
    Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28718.
    PubMed     Abstract available


  449. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28696.
    PubMed     Abstract available


  450. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  451. PRANATA R, Tondas AE, Vania R, Toruan MPL, et al
    Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28709.
    PubMed     Abstract available


  452. COSTANTINI CR, Denk MA, De Macedo RM, Tarbine SG, et al
    Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28699.
    PubMed     Abstract available


  453. SONG L, Sun Z, Guan C, Yan H, et al
    First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes.
    Catheter Cardiovasc Interv. 2020 Jan 7. doi: 10.1002/ccd.28722.
    PubMed     Abstract available


  454. VALENTI R, Migliorini A, De Gregorio MG, Martone R, et al
    Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion.
    Catheter Cardiovasc Interv. 2020;95:145-153.
    PubMed     Abstract available


  455. CEREDA AF, De Luca F, Lanzone AM, Cottini M, et al
    Case report and systematic review of iatrogenic left atrial dissection in different cardiovascular specialties: A common treatment for an uncommon complication?
    Catheter Cardiovasc Interv. 2020;95:E30-E36.
    PubMed     Abstract available


  456. XENOGIANNIS I, Vemmou E, Nikolakopoulos I, Brilakis ES, et al
    Challenges associated with treatment of left internal mammary artery graft thrombosis.
    Catheter Cardiovasc Interv. 2020;95:E17-E20.
    PubMed     Abstract available


  457. KITANO D, Takayama T, Fukamachi D, Migita S, et al
    Impact of low-dose prasugrel on platelet reactivity and cardiac dysfunction in acute coronary syndrome patients requiring primary drug-eluting stent implantation: A randomized comparative study.
    Catheter Cardiovasc Interv. 2020;95:E8-E16.
    PubMed     Abstract available


  458. FIORILLI PN, Kobayashi T, Giri J, Hirshfeld JW Jr, et al
    Strategies for radiation exposure-sparing in fluoroscopically guided invasive cardiovascular procedures.
    Catheter Cardiovasc Interv. 2020;95:118-127.
    PubMed     Abstract available


  459. MIZUTANI K, Hara M, Nakao K, Yamaguchi T, et al
    Association between debulking area of rotational atherectomy and platform revolution speed-Frequency domain optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2020;95:E1-E7.
    PubMed     Abstract available


  460. MERINOPOULOS I, Wickramarachchi U, Wardley J, Khanna V, et al
    Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:105-108.
    PubMed     Abstract available


  461. ZIVELONGHI C, van Kuijk JP, Poletti E, Suttorp MJ, et al
    A "minimalistic hybrid algorithm" in coronary chronic total occlusion revascularization: Procedural and clinical outcomes.
    Catheter Cardiovasc Interv. 2020;95:97-104.
    PubMed     Abstract available


  462. CHAN CY, Chan YH
    Double trapper technique: A novel technique to facilitate retrograde wire externalization in aorto-ostial chronic total occlusion intervention without using snare.
    Catheter Cardiovasc Interv. 2020;95:170-173.
    PubMed     Abstract available


  463. SURYADEVARA R, Brown ED, Green SM, Scott TD, et al
    A randomized controlled trial to assess operator radiation exposure from cardiac catheterization procedures using RAD BOARD(R) with standard pelvic shielding versus standard pelvic shielding alone.
    Catheter Cardiovasc Interv. 2020;95:83-88.
    PubMed     Abstract available


    December 2019
  464. GARCIA-GARCIA HM, Adamo M, Soud M, Yacob O, et al
    Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX)
    Catheter Cardiovasc Interv. 2019 Dec 28. doi: 10.1002/ccd.28661.
    PubMed     Abstract available


  465. SHROFF AR, Gulati R, Drachman DE, Feldman DN, et al
    SCAI expert consensus statement update on best practices for transradial angiography and intervention.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28672.
    PubMed     Abstract available


  466. GAO G, Zhang D, Song C, Xu H, et al
    Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28673.
    PubMed     Abstract available


  467. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


  468. LI J, Li Y, Qiu M, Li Z, et al
    Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28653.
    PubMed     Abstract available


  469. YAN L, Li P, Wang Y, Han D, et al
    Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28652.
    PubMed     Abstract available


  470. KHEIFETS M, Vaknin-Assa H, Greenberg G, Assali A, et al
    Outcomes of primary percutaneous cardiac intervention for ST elevation myocardial infarction with a saphenous vein graft culprit.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28662.
    PubMed     Abstract available


  471. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  472. YAP J, Teo TY, Foong P, Binte Hussin N, et al
    A randomized controlled trial on the effectiveness of a portable patient education video prior to coronary angiography and angioplasty.
    Catheter Cardiovasc Interv. 2019 Dec 22. doi: 10.1002/ccd.28655.
    PubMed     Abstract available


  473. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    PubMed     Abstract available


  474. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  475. RIANGWIWAT T, Mumtaz T, Blankenship JC
    Barriers to use of radial access for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28619.
    PubMed     Abstract available


  476. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


  477. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


  478. CHANDIRAMANI R, Mehran R
    Examining the role of diabetes mellitus in ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019;94:926-927.
    PubMed    


    November 2019
  479. OMRAN J, Enezate T, Abdullah O, Al-Dadah A, et al
    Outcomes of fractional flow reserve-guided percutaneous coronary interventions in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28611.
    PubMed     Abstract available


  480. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  481. AMR BS, Lippmann M, Tobbia P, Isom N, et al
    Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
    Catheter Cardiovasc Interv. 2019 Nov 26. doi: 10.1002/ccd.28618.
    PubMed     Abstract available


  482. VALLABHAJOSYULA S, El Hajj SC, Bell MR, Prasad A, et al
    Intravascular ultrasound, optical coherence tomography, and fractional flow reserve use in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 14. doi: 10.1002/ccd.28543.
    PubMed     Abstract available


  483. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  484. ALSANJARI O, Chouari T, Williams T, Myat A, et al
    Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28532.
    PubMed     Abstract available


  485. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  486. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  487. SULLIVAN AE, Nanna MG, Rao SV, Cantrell S, et al
    A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535.
    PubMed     Abstract available


  488. XENOGIANNIS I, Nikolakopoulos I, Vemmou E, Brilakis ES, et al
    Chronic total occlusion recanalization for myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28590.
    PubMed     Abstract available


  489. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  490. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


    October 2019
  491. SONG C, Zhou C, Zhang J, Feng X, et al
    Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
    Catheter Cardiovasc Interv. 2019 Oct 29. doi: 10.1002/ccd.28564.
    PubMed     Abstract available


  492. BATCHELOR R, Liu DH, Bloom J, Noaman S, et al
    Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 26. doi: 10.1002/ccd.28561.
    PubMed     Abstract available


  493. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  494. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  495. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  496. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  497. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available


  498. ARMSTRONG AK, Zampi JD, Itu LM, Benson LN, et al
    Use of 3D rotational angiography to perform computational fluid dynamics and virtual interventions in aortic coarctation.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28507.
    PubMed     Abstract available


  499. POLETTI E, Azzalini L, Ayoub M, Ojeda S, et al
    Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.
    Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513.
    PubMed     Abstract available


  500. BRENER MI, Green P, Parikh SA, Sethi SS, et al
    Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome.
    Catheter Cardiovasc Interv. 2019 Oct 8. doi: 10.1002/ccd.28525.
    PubMed     Abstract available


    September 2019
  501. STAUDACHER DL, Schmitt C, Zirlik A, Zehender M, et al
    Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Sep 11. doi: 10.1002/ccd.28495.
    PubMed     Abstract available


  502. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


  503. HIRAI T, Kearney K, Kataruka A, Gosch KL, et al
    Initial report of safety and procedure duration of robotic-assisted chronic total occlusion coronary intervention.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28477.
    PubMed     Abstract available


  504. WHITBECK MG
    Treatment of focal distal abdominal aortic stenosis with the GORE VIABAHN VBX balloon expandable covered stent.
    Catheter Cardiovasc Interv. 2019 Sep 2. doi: 10.1002/ccd.28478.
    PubMed     Abstract available


  505. TARANTINI G, Giacoppo D
    Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery?
    Catheter Cardiovasc Interv. 2019;94:385-386.
    PubMed     Abstract available


    August 2019
  506. HONG SJ, Kim BK, Kim YJ, Rha SW, et al
    Incidence, predictors, and outcomes of distal vessel expansion on follow-up intravascular ultrasound after recanalization of chronic total occlusions using new-generation drug-eluting stents: Data from the CTO-IVUS randomized trial.
    Catheter Cardiovasc Interv. 2019 Aug 28. doi: 10.1002/ccd.28461.
    PubMed     Abstract available


  507. ALUSHI B, Lauten A, Ndrepepa G, Leistner DM, et al
    Procedural and clinical performance of dual- versus single-catheter strategy for transradial coronary angiography: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28458.
    PubMed     Abstract available


  508. KANDZARI DE, Karmpaliotis D, Kini AS, Moses JW, et al
    Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPER
    Catheter Cardiovasc Interv. 2019 Aug 24. doi: 10.1002/ccd.28436.
    PubMed     Abstract available


  509. NAIDU SS, Daniels MJ, Elmariah S, Garcia S, et al
    Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank.
    Catheter Cardiovasc Interv. 2019 Aug 23. doi: 10.1002/ccd.28449.
    PubMed    


  510. MARQUIS-GRAVEL G, Zeitouni M, Kochar A, Jones WS, et al
    Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies.
    Catheter Cardiovasc Interv. 2019 Aug 21. doi: 10.1002/ccd.28455.
    PubMed     Abstract available


  511. GOEL S, Pasam RT, Raheja H, Gotesman J, et al
    Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28451.
    PubMed     Abstract available


  512. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Abstract available


  513. POTTS J, Mohamed MO, Lopez Mattei JC, Iliescu CA, et al
    Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28432.
    PubMed     Abstract available


  514. KOGAME N, Chichareon P, De Wilder K, Takahashi K, et al
    Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28428.
    PubMed     Abstract available


  515. ROULE V, Schwob L, Lemaitre A, Bignon M, et al
    Residual atherothrombotic burden after primary percutaneous coronary intervention and myocardial reperfusion-An optical frequency domain imaging study.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28429.
    PubMed     Abstract available


  516. IANNACCONE M, Abdirashid M, Annone U, Saint-Hilary G, et al
    Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28410.
    PubMed     Abstract available


  517. DOSHI R, Patel K, Desai R, Patel P, et al
    Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28431.
    PubMed     Abstract available


  518. WATANABE H, Shiomi H, Morimoto T, Furukawa Y, et al
    Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420.
    PubMed     Abstract available


  519. AL-ANI A, Hoffmann P, von Lueder T, Opdahl A, et al
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Aug 4. doi: 10.1002/ccd.28419.
    PubMed     Abstract available


    July 2019
  520. FLAHERTY MP, Moses JW, Westenfeld R, Palacios I, et al
    Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400.
    PubMed     Abstract available


  521. CASTRO-MEJIA AF, Ortega-Armas ME, Mejia-Renteria H, Gonzalo N, et al
    Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jul 26. doi: 10.1002/ccd.28404.
    PubMed     Abstract available


  522. KOLTOWSKI L, Tomaniak M, Ochijewicz D, Maksym J, et al
    Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
    Catheter Cardiovasc Interv. 2019 Jul 25. doi: 10.1002/ccd.28414.
    PubMed     Abstract available


  523. KAR S
    Systematic review of alternative access for cardiac catheterization and percutaneous coronary intervention: Dorsal distal radial and ulnar artery catheterization.
    Catheter Cardiovasc Interv. 2019 Jul 22. doi: 10.1002/ccd.28398.
    PubMed     Abstract available


  524. GASPARINI GL, Garbo R, Gagnor A, Oreglia J, et al
    Feasibility and safety of distal radial access for percutaneous coronary intervention using a 7 FR sheath.
    Catheter Cardiovasc Interv. 2019 Jul 21. doi: 10.1002/ccd.28397.
    PubMed    


  525. SAADAT N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, et al
    Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28396.
    PubMed     Abstract available


  526. LI Y, Tian F, Wang J, Xie M, et al
    Pseudoaneurysm of the non-coronary sinus of Valsalva: A rare complication of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28407.
    PubMed     Abstract available


  527. RAFEEDHEEN R, Agarwal SK, Meek JC, Uretsky BF, et al
    Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.
    PubMed     Abstract available


  528. KIRTANE AJ, Yeung AC, Ball M, Carr J, et al
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28392.
    PubMed     Abstract available


  529. POSTMA W, Fabris E, Van der Ent M, Hermanides R, et al
    Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.
    Catheter Cardiovasc Interv. 2019 Jul 3. doi: 10.1002/ccd.28376.
    PubMed     Abstract available


    June 2019
  530. HE Y, Cheng XF, Wang K, Liu T, et al
    Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 29. doi: 10.1002/ccd.28384.
    PubMed     Abstract available


  531. AL-KHADRA Y, Alraies MC, Darmoch F, Pacha HM, et al
    Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jun 28. doi: 10.1002/ccd.28383.
    PubMed     Abstract available


  532. HIRAI T, Jacob D, Main ML, Grantham JA, et al
    A case of robotic assisted percutaneous coronary intervention of the left main coronary artery in a patient with very late baffle stenosis after surgical correction of anomalous left coronary artery from the pulmonary artery.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28382.
    PubMed     Abstract available


  533. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.
    PubMed    


  534. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Abstract available


  535. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed    


  536. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Abstract available


  537. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Abstract available


    May 2019
  538. INOGUCHI Y, Kaku B, Kitagawa N, Katsuda S, et al
    Novel use of a stent graft for uncontrollable intraprocedural stent thrombosis in a patient with acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28346.
    PubMed     Abstract available


  539. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Abstract available


  540. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Abstract available


  541. ZHANG J, Gao X, Ge Z, Han L, et al
    Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial.
    Catheter Cardiovasc Interv. 2019 May 22. doi: 10.1002/ccd.28308.
    PubMed     Abstract available


  542. CHEN Y, Yin T, Xi S, Zhang S, et al
    A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28325.
    PubMed     Abstract available


  543. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Abstract available


  544. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed    


  545. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed    


  546. BAUER T, Zeymer U, Diallo A, Vicaut E, et al
    Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.
    Catheter Cardiovasc Interv. 2019 May 8. doi: 10.1002/ccd.28318.
    PubMed     Abstract available


  547. SEKIGUCHI M, Muramatsu T, Kishi K, Muto M, et al
    Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28315.
    PubMed     Abstract available


    April 2019
  548. MOSCARELLA E, Ielasi A, Beneduce A, Ferrante G, et al
    One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28305.
    PubMed     Abstract available


  549. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  550. POZZI M, Flagiello M, Armoiry X, Generali T, et al
    Extracorporeal life support in the multidisciplinary management of cardiogenic shock complicating acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28316.
    PubMed     Abstract available


  551. TOVAR FORERO MN, van Zandvoort L, Masdjedi K, Diletti R, et al
    Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28304.
    PubMed     Abstract available


  552. ISHIKAWA M, Muramatsu T, Nanasato M, Nagasaka R, et al
    Associations of coronary plaque characteristics by integrated backscatter intravascular ultrasound with detectability of vessel external elastic lamina using optical frequency domain imaging in human coronary arteries: A sub-analysis of the MISTIC-1 t
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28218.
    PubMed     Abstract available


  553. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Abstract available


  554. TIJSSEN RYG, van der Schaaf RJ, Kraak RP, Vink MA, et al
    Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
    Catheter Cardiovasc Interv. 2019 Apr 9. doi: 10.1002/ccd.28193.
    PubMed     Abstract available


  555. KWOK CS, Sirker A, Farmer AD, Kontopantelis E, et al
    In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222.
    PubMed     Abstract available


    March 2019
  556. JIMENEZ-QUEVEDO P, Brugaletta S, Cequier A, Iniguez A, et al
    Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial.
    Catheter Cardiovasc Interv. 2019 Mar 20. doi: 10.1002/ccd.28194.
    PubMed     Abstract available


  557. BUTTER C, Okamoto M, Schymik G, Jacobshagen C, et al
    Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry.
    Catheter Cardiovasc Interv. 2019 Mar 13. doi: 10.1002/ccd.28164.
    PubMed     Abstract available


  558. CRIMI G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, et al
    The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Mar 9. doi: 10.1002/ccd.28167.
    PubMed     Abstract available


    February 2019
  559. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Abstract available


  560. AOI S, Htun WW, Freeo S, Lee S, et al
    Distal transradial artery access in the anatomical snuffbox for coronary angiography as an alternative access site for faster hemostasis.
    Catheter Cardiovasc Interv. 2019 Feb 24. doi: 10.1002/ccd.28155.
    PubMed     Abstract available


  561. YE Z, Lai Y, Yao Y, Mintz GS, et al
    Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28094.
    PubMed     Abstract available


  562. RAMZY J, Andrianopoulos N, Roberts L, Duffy SJ, et al
    Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28145.
    PubMed     Abstract available


  563. WELCH TL, Law LA, Lanzino G, Lanier WL, et al
    Hydraulic stimulation of carotid artery baroreceptors as a likely cause of transient asystolic cardiac arrest during diagnostic angiography or surgical endarterectomy.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28126.
    PubMed     Abstract available


  564. FU Y, Gu XS, Hao GZ, Jiang YF, et al
    Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28112.
    PubMed     Abstract available


  565. IKEDA N, Kubota S, Okazaki T, Iijima R, et al
    The predictors of complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28133.
    PubMed     Abstract available


  566. TAKAYUKI G, Volker H, Axel H, Dirk F, et al
    Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.
    Catheter Cardiovasc Interv. 2019 Feb 17. doi: 10.1002/ccd.28129.
    PubMed     Abstract available


  567. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Abstract available


  568. LIGON RA, Petit CJ
    Working backward: Retrograde balloon angioplasty of atretic arteries in chronic thromboembolic pulmonary hypertension.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28115.
    PubMed     Abstract available


    January 2019
  569. RUBIMBURA V, Rostain L, Duval AM, Akakpo S, et al
    Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.
    Catheter Cardiovasc Interv. 2019 Jan 31. doi: 10.1002/ccd.28084.
    PubMed     Abstract available


  570. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Abstract available


  571. HE Y, Zhang D, Yin D, Zhu C, et al
    Development and validation of a risk scoring system based on baseline angiographic results by visual estimation for risk prEdiction of side-branch OccLusion in coronary bifurcation InterVEntion: The baseline V-RESOLVE score.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28068.
    PubMed     Abstract available


  572. HUANG X, Redfors B, Chen S, Gersh BJ, et al
    Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28096.
    PubMed     Abstract available


  573. REED GW, Rossi JE, Masri A, Griffin BP, et al
    Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28107.
    PubMed     Abstract available


  574. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  575. NDREPEPA G, Cassese S, Hashorva D, Kufner S, et al
    Relationship of left ventricular end-diastolic pressure with extent of myocardial ischemia, myocardial salvage and long-term outcome in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28098.
    PubMed     Abstract available


  576. SHARMA SK, Bolduan RW, Patel MR, Martinsen BJ, et al
    Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28099.
    PubMed     Abstract available


  577. FAGGIONI M, Baber U, Chandrasekhar J, Sartori S, et al
    Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033.
    PubMed     Abstract available


  578. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Abstract available


  579. KHEIRI B, Abdalla A, Osman M, Barbarawi M, et al
    Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28075.
    PubMed     Abstract available


  580. POTTS J, Nagaraja V, Al Suwaidi J, Brugaletta S, et al
    The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28072.
    PubMed     Abstract available


  581. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Abstract available


  582. CHAN CY, Wu EB, Yan BP, Tsuchikane E, et al
    Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry.
    Catheter Cardiovasc Interv. 2019 Jan 3. doi: 10.1002/ccd.28064.
    PubMed     Abstract available


  583. AHN SG, Lee JW, Youn YJ, Lee SH, et al
    In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2019 Jan 2. doi: 10.1002/ccd.28032.
    PubMed     Abstract available


    December 2018
  584. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Abstract available


  585. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Abstract available


  586. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Abstract available


  587. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Abstract available


  588. NEUPANE S, Khawaja O, Edla S, Singh H, et al
    Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28045.
    PubMed     Abstract available


  589. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Abstract available


  590. IANNACCONE M, D'ascenzo F, Piazza F, De Benedictis M, et al
    Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28037.
    PubMed     Abstract available


  591. CORCOS T
    Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Dec 11. doi: 10.1002/ccd.28016.
    PubMed     Abstract available


  592. ANDO T, Aoi S, Ashraf S, Villablanca PA, et al
    Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28025.
    PubMed     Abstract available


  593. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  594. GOPALAKRISHNAN PP, Manoharan P, Shekhar C, Seto A, et al
    Redefining the fluoroscopic landmarks for common femoral arterial puncture during cardiac catheterization: Femoral angiogram and computed tomography angiogram (FACT) study of common femoral artery anatomy.
    Catheter Cardiovasc Interv. 2018 Dec 7. doi: 10.1002/ccd.27991.
    PubMed     Abstract available


  595. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


    November 2018
  596. FINN MT, Doshi D, Cleman J, Song L, et al
    Intravascular ultrasound analysis of intraplaque versus subintimal tracking in percutaneous intervention for coronary chronic total occlusions: One year outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.27958.
    PubMed     Abstract available


  597. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Abstract available


  598. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27986.
    PubMed     Abstract available


  599. JACOBZON E, Wolak A, Fink D, Silberman S, et al
    Delayed aortic dissection and valve thrombosis after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27994.
    PubMed     Abstract available


  600. SCHUMACHER SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, et al
    Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27945.
    PubMed     Abstract available


  601. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Abstract available


  602. GURM HS, Mavromatis K, Bertolet B, Kereiakes DJ, et al
    Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert plus contrast reduction system.
    Catheter Cardiovasc Interv. 2018 Nov 4. doi: 10.1002/ccd.27935.
    PubMed     Abstract available


    October 2018
  603. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed     Abstract available


  604. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  605. WELT FGP, Klein LW, Tamis-Holland J, Blankenship J, et al
    Views of Appropriate Use Criteria for catheterization and percutaneous coronary revascularization by practicing interventional cardiologists: Results of a survey of American College of Cardiology Interventional Section members.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27931.
    PubMed     Abstract available


    September 2018
  606. DAVID SW, Khan ZA, Patel NC, Metzger DC, et al
    Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27905.
    PubMed     Abstract available


  607. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: